Praziquantel NEW
| Price | $29 |
| Package | 500mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-06-16 |
Product Details
| Product Name: Praziquantel | CAS No.: 55268-74-1 |
| Purity: 99.86% | Supply Ability: 10g |
| Release date: 2025/06/16 |
Product Introduction
Bioactivity
| Name | Praziquantel |
| Description | Praziquantel (Droncit) increases the permeability of the tegument of susceptible worms, resulting in an influx and increase in intra-tegumental calcium leading to rapid contractions and paralysis of the worm's musculature through a subsequent increase in levels of calcium in the sarcoplasmic reticulum. Praziquantel is a pyrazinoisoquinoline derivative with anthelminthic property. In addition, vacuolization of the tegumental syncytium and blebbing results in tegument disintegration, leads to antigen exposure and elicit host defense responses to the worm. |
| Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
| Solubility Information | DMSO : 70 mg/mL (224.06 mM), Sonication is recommended. Ethanol : 59 mg/mL (188.85 mM), Sonication is recommended. |
| Keywords | Praziquantel | Parasite | Inhibitor | inhibit | CalciumChannel | Calcium Channel | Antibiotic |
| Inhibitors Related | Neomycin sulfate | Ampicillin sodium | Kojic acid | Doxycycline (hyclate) | Kanamycin sulfate | Urethane | L-Ascorbic acid | Sulfamethoxazole sodium | Hydroxychloroquine | Doxycycline | EDTA copper(II) disodium salt | L-Ascorbic acid sodium salt |
| Related Compound Libraries | Anti-Parasitic Compound Library | Failed Clinical Trials Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Ion Channel Targeted Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $29.00/500mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-06-16 | |
| $5.00/1KG |
VIP1Y
|
Wuhan JiyunZen Tech Co., Ltd.
|
2025-06-12 | |
| $0.00/1kg |
VIP1Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-05-09 | |
| $1.10/1g |
VIP5Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-04-02 | |
| $0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-03-31 | |
| $20.00/1KG |
Shandong Xuhuang New material CoLTD
|
2025-02-25 | ||
| $40.00/1kg |
VIP5Y
|
Hebei Lingding Biotechnology Co., Ltd.
|
2025-01-13 | |
| $360.00/1kg |
VIP1Y
|
Guangdong Junhua Chemical Co., Ltd
|
2024-12-25 | |
| $150.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-11-27 | |
| $10.00/25kg |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-10-24 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY